# Innovative Drugs

From Hype to Harvest: China’s Top-Performing Funds Shrink as Market Rotates Toward Value

A sharp early-July correction in China's top-performing equity funds has wiped out significant gains in the tech sector, triggering a rotation into innovative drugs and robotics. This shift signals a transition from speculative AI-driven growth to a focus on fundamental earnings and valuation recovery in undervalued sectors.